Aripiprazole in the real-world treatment for irritability associated with autism spectrum disorder in children and adolescents in Japan: 52-week post-marketing surveillance.

Authors: Sugimoto, Yuna¹ (AUTHOR) Sugimoto.Yuna@otsuka.jp, Yamamura, Kayo¹ (AUTHOR), Takayama, Tomoyo¹ (AUTHOR), Fukuta, Yasuhiko¹ (AUTHOR), Aoki, Kazuo² (AUTHOR), Mikami, Katsunaka³ (AUTHOR), Tomoda, Akemi⁴ (AUTHOR)

Source: BMC Psychiatry. 4/22/2021, Vol. 21 Issue 1, p1-12. 12p. 1 Diagram, 6 Charts, 5 Graphs.

Subject Terms: *CHILDREN with autism spectrum disorders, *DRUG side effects, *ARIPIPRAZOLE, *AUTISM spectrum disorders, *MULTIPLE regression analysis

Geographic Terms: JAPAN

This result is not displayed to guests.
Login for full access.